Quick facts

• Zoë operates by a coiled spring that generates power. When the spring releases, the insulin is released through a tiny orifice at the end of the injector (the orifice measures only 0.006’’ compared to the .012’’ diameter of the needle). It then forms a micro-jet stream needed to pass through the skin and into the subcutaneous area of the tissue.

• Zoë has a range of comfort settings that allows for the adjustment of the penetration pressure of the injection depending on variables such as insulin type, insulin volume, skin type, injection location, and the animal’s size and age.

• Studies show that Zoë is more accurate than the needle and syringe. Its ½ unit increments allow for a more precise measurement.

• This same jet injection technology used in Zoë has been recognized by the FDA as a Class II Medical Device since 1985. It has been used to effectively treat and manage diabetes in humans for over 20 years.

• Clinical studies at Atlantic Veterinary College in PEI, Canada, concluded that the jet is just as effective in treating diabetes in animals as it is in humans.

• Zoë is so easy to clean and use that nearly anyone can administer the injection. Family members, pet sitters, neighbors, etc. can easily learn and be comfortable doing the injection should the pet owner be unavailable.

• Zoë is an environmental friend as it reduces the number of needles and syringes that present an ongoing health, safety, and environmental concern. The device is also completely reusable, eliminating the problems of disposables tips and cartridges.